Jinhuatuo Received Millions Of Dollars In Series A Financing

According to VCbeat, Chinese medicine platform Jinhuatuo just received a few million dollars in Series A financing. This round of financing was led by Gongxiao Capital. The funds will be used for teaching method development and building a new model for Chinese medicine diagnosis.

Jinhuatuo was founded in 2015 in Guangzhou, it's the only company in China that does Chinese medicine training. At this moment, Jinhuatuo provides quality offline training and online courses for people who want to work in the field of Chinese medicine in Guangdong province, and the company is now working with many hospitals.

Jinhuatuo has digitized and standardized much knowledge of Chinese medicine, and has invited more than 10 old Chinese medicine practitioners in the fields of acupuncture, medicine, typhoid, tumor and more to make network courses for students to learn, and to create the most advanced teaching system.

Jinhuatuo has invested more than 3 million RMB in education in Guangdong Province in the past 2 years. It estimates that the interest rate of Chinese medicine learning among the general public is about 0.3%, that is, among the 1,000 people who have paid attention to the Jinhuatuo propaganda materials, three people will eventually purchase Jinhuatuo's 10,000 RMB courses up to tens of thousands RMB of training courses. As a result, Jinhuatuo's potential users nationwide are about 140,000, corresponding to a market size of about 15 billion RMB.

Gongxiao Capital is a new investment firm in China.